Clover Health FY24 adjusted EBITDA $70M, net loss improves $164M; 2025 revenue guidance $1.8-1.875B

CLOVER HEALTH INVESTMENTS, CORP. /DE

Full year 2024 GAAP net loss from continuing ops narrowed to $46M from $210M in 2023 (improvement of $164M).
Full year 2024 Adjusted EBITDA was $70M, reversing a $42M loss in 2023; Q4 Adj. EBITDA $7.8M vs -$16.7M.
Insurance revenue $1.344B for 2024 (+8.8% YoY); Insurance BER improved to 81.2% from 86.5%.
For 2025, guides insurance revenue $1.8-$1.875B (37% growth) and Adjusted EBITDA $45M-$70M.
Average Medicare Advantage membership expected 103k-107k in 2025 (~30% growth YoY at midpoint).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.